Niederer Kraft Frey advised a syndicate of 15 banks, led by Goldman Sachs, Morgan Stanley and UBS as joint global coordinators, in connection with the initial...
Galderma’s CHF2.3 Billion IPO On SIX Swiss Exchange
TOLREMO Therapeutics AG’s CHF34.1 Million Series A Financing Round
Homburger advised TOLREMO therapeutics AG on the extension of its Series A financing round. TOLREMO therapeutics AG has completed its Series A financing, bringing the total amount...
Ironwood Pharmaceuticals’ $1 Billion Acquisition of VectivBio Holding
Advestra and Latham & Watkins advise Ironwood. Homburger AG serves as legal and tax advisor to VectivBio on the transaction. Goodwin advises Centerview Partners. VectivBio Holding...
Liontrust’s Public Exchange Offer for Acqusition of GAM
Homburger AG advises GAM on the transaction; MLL Legal is representing Liontrust. GAM Holding AG (GAM) announced that it had entered into an agreement with Liontrust Asset...
Noema Pharma AG’s $112 Million Series B Financing Round
Homburger AG advised Noema Pharma AG on the transaction. Noema Pharma AG announced that it has successfully closed an oversubscribed Series B financing round, raising CHF...
Tandem Diabetes Care’s Acquisition of AMF Medical
Homburger advised AMF Medical and its shareholders on the deal, while Baker McKenzie Switzerland advised Tandem Diabetes Care. Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global...
VectivBio’s $125 Million Shares Offering
Latham & Watkins represented the underwriters in the offering. Homburger advised VectivBio. VectivBio Holding AG (Nasdaq: VECT) has announced the pricing of an underwritten offering of 16,700,000...
VectivBio’s $54 Million Aggregate Financing
Homburger advised VectivBio on the deal. NKF acted as Swiss counsel to SVB Securities, Piper Sandler and LifeSci Capital in the public offering. VectivBio Holding AG (Nasdaq:...
Coinbase’s Acquihire of BRD
Homburger acted as Swiss counsel to Coinbase. Coinbase (Nasdaq: COIN), a leading provider of end-to-end financial infrastructure and technology for the cryptoeconomy, announced its acquihire of BRD,...
anthera Pharmaceuticals’ CHF 15 Million Private Convertible Bonds And CHF 10 Million Exchangeable Notes
Homburger advised Santhera in this matter. Santhera Pharmaceuticals annouced a strengthening of its capital structure via placement of private convertible bonds of CHF 15 million and upsizing of...
Santhera Pharmaceuticals’ CHF 20 Million Shares Private Placement
Pestalozzi advised H.C. Wainwright on the deal. Homburger advised Santhera. Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular...
VectivBio’s Acquisition of Comet Therapeutics
Homburger advised VectivBio Holding AG in this matter. VectivBio Holding AG announced the acquisition of Comet Therapeutics, Inc., a biotechnology company that has been developing drugs...